missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human HECTD3 (aa 181-269) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (98%), Rat (98%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
E3 ubiquitin ligases accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Mediates ubiquitination of TRIOBP and its subsequent proteasomal degradation, thus facilitating cell cycle progression by regulating the turn-over of TRIOBP. Mediates also ubiquitination of STX8.
Specifications
Specifications
| Accession Number | Q5T447 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 79654 |
| Name | Human HECTD3 (aa 181-269) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1700064K09Rik; AI467540; AW743312; E3 ubiquitin-protein ligase HECTD3; HECT domain containing 3; HECT domain containing E3 ubiquitin protein ligase 3; HECT domain E3 ubiquitin protein ligase 3; HECT domain-containing protein 3; HECTD3; HECT-type E3 ubiquitin transferase HECTD3; probable E3 ubiquitin-protein ligase HECTD3; RGD1309823 |
| Common Name | HECTD3 |
| Show More |